Clinical Trial Update: Safety & Efficacy Study of Gemcitabine...With High Dose IV Vit. C (HDIVC) [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated gemcitabine with high-dose intravenous vitamin C in metastatic pancreatic cancer. The study was terminated, and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Ascorbic acid (intravenous) (ascorbic acid)
• Gemzar (gemcitabine)

Snippet

Sponsor: Eastern Regional Medical Center | Conditions: Metastatic Adenocarcinoma of the Pancreas | Phase 1 | Status: TERMINATED | Results posted: 2014-12-01